271 related articles for article (PubMed ID: 23190503)
1. The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).
Moynihan C; Lewis R; Hall E; Jones E; Birtle A; Huddart R;
Trials; 2012 Nov; 13():228. PubMed ID: 23190503
[TBL] [Abstract][Full Text] [Related]
2. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).
Paramasivan S; Huddart R; Hall E; Lewis R; Birtle A; Donovan JL
Trials; 2011 Mar; 12():78. PubMed ID: 21406089
[TBL] [Abstract][Full Text] [Related]
3. Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
Huddart RA; Birtle A; Maynard L; Beresford M; Blazeby J; Donovan J; Kelly JD; Kirkbank T; McLaren DB; Mead G; Moynihan C; Persad R; Scrase C; Lewis R; Hall E
BJU Int; 2017 Nov; 120(5):639-650. PubMed ID: 28453896
[TBL] [Abstract][Full Text] [Related]
4. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
5. Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy).
Harrop E; Kelly J; Griffiths G; Casbard A; Nelson A;
Trials; 2016 Jan; 17():35. PubMed ID: 26787177
[TBL] [Abstract][Full Text] [Related]
6. How informed is declared altruism in clinical trials? A qualitative interview study of patient decision-making about the QUEST trials (Quality of Life after Mastectomy and Breast Reconstruction).
Bidad N; MacDonald L; Winters ZE; Edwards SJ; Emson M; Griffin CL; Bliss J; Horne R
Trials; 2016 Sep; 17(1):431. PubMed ID: 27590594
[TBL] [Abstract][Full Text] [Related]
7. What can we learn from trial decliners about improving recruitment? Qualitative study.
Hughes-Morley A; Young B; Hempel RJ; Russell IT; Waheed W; Bower P
Trials; 2016 Oct; 17(1):494. PubMed ID: 27733181
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
Mills N; Donovan JL; Smith M; Jacoby A; Neal DE; Hamdy FC
Control Clin Trials; 2003 Jun; 24(3):272-82. PubMed ID: 12757993
[TBL] [Abstract][Full Text] [Related]
9. Recruiting and consenting into a peripartum trial in an emergency setting: a qualitative study of the experiences and views of women and healthcare professionals.
Lawton J; Snowdon C; Morrow S; Norman JE; Denison FC; Hallowell N
Trials; 2016 Apr; 17():195. PubMed ID: 27066777
[TBL] [Abstract][Full Text] [Related]
10. Exploring non-participation in primary care physical activity interventions: PACE-UP trial interview findings.
Normansell R; Holmes R; Victor C; Cook DG; Kerry S; Iliffe S; Ussher M; Fox-Rushby J; Whincup P; Harris T
Trials; 2016 Apr; 17():178. PubMed ID: 27039181
[TBL] [Abstract][Full Text] [Related]
11. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Can bladder preservation therapy come to the center stage?
Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
[TBL] [Abstract][Full Text] [Related]
14. Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.
Rooshenas L; Elliott D; Wade J; Jepson M; Paramasivan S; Strong S; Wilson C; Beard D; Blazeby JM; Birtle A; Halliday A; Rogers CA; Stein R; Donovan JL; ; ; ; ; ;
PLoS Med; 2016 Oct; 13(10):e1002147. PubMed ID: 27755555
[TBL] [Abstract][Full Text] [Related]
15. Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers.
Walker M; Doiron RC; French SD; Feldman-Stewart D; Siemens DR; Mackillop WJ; Booth CM
Clin Oncol (R Coll Radiol); 2017 Dec; 29(12):818-826. PubMed ID: 28951003
[TBL] [Abstract][Full Text] [Related]
16. Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed.
Huddart RA; Hall E; Lewis R; Birtle A;
BJU Int; 2010 Sep; 106(6):753-5. PubMed ID: 20707796
[No Abstract] [Full Text] [Related]
17. Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study.
Dellson P; Nilsson K; Jernström H; Carlsson C
Trials; 2018 Sep; 19(1):528. PubMed ID: 30268150
[TBL] [Abstract][Full Text] [Related]
18. Women's views and experiences of two alternative consent pathways for participation in a preterm intrapartum trial: a qualitative study.
Sawyer A; Chhoa C; Ayers S; Pushpa-Rajah A; Duley L
Trials; 2017 Sep; 18(1):422. PubMed ID: 28886747
[TBL] [Abstract][Full Text] [Related]
19. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
Trials; 2014 Feb; 15():62. PubMed ID: 24548781
[TBL] [Abstract][Full Text] [Related]
20. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
